학술논문
CONTACT-2: Phase 3 study of cabozantinib (C) plus atezolizumab (A) vs second novel hormonal therapy (NHT) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).
Document Type
Article
Author
Agarwal, Neeraj; Azad, Arun; Carles, Joan; Matsubara, Nobuaki; Oudard, Stephane; Saad, Fred; Merseburger, Axel S.; Soares, Andrey; McGregor, Bradley Alexander; Zurawski, Bogdan; North, Scott A.; Tsiatas, Marinos; Bondarenko, Igor; Alfie, Margarita Sonia; Evilevitch, Lena; Sharma, Keerti; Nandoskar, Prachi; Ferraldeschi, Roberta; Wang, Fong; Pal, Sumanta Kumar
Source
Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, p18-18, 235p
Subject
Language
ISSN
0732183X